Metformin cream for psoriasis vulgaris, Cairo University trial
Summary
NIH/NLM registered a new clinical trial (NCT07516821) on ClinicalTrials.gov investigating topical metformin cream for treating psoriasis vulgaris. The Phase 2 study is sponsored by Cairo University in Egypt with an estimated enrollment of 60 participants. Results posting is required under FDAAA 801 for applicable trials.
What changed
A new clinical trial registration appeared on ClinicalTrials.gov for a Phase 2 study evaluating the efficacy and safety of metformin cream in patients with mild-to-moderate psoriasis vulgaris. The single-arm trial sponsored by Cairo University plans to enroll approximately 60 participants.
Clinical trial sponsors and investigators should note that ClinicalTrials.gov registrations are public record and may trigger FDAAA 801 compliance obligations if the trial involves US sites or meets other applicability criteria. Results must be submitted within 12 months of primary completion date for applicable trials.
What to do next
- Monitor for trial updates and results postings
- Ensure FDAAA 801 compliance if US-based collaborators are involved
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
CFR references
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.